Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review-Part I

The challenging severity of some infections, especially in critically ill patients, makes the diffusion of antimicrobial drugs within tissues one of the cornerstones of chemotherapy. The knowledge of how antibacterial agents penetrate tissues may come from different sources: preclinical studies in animal models, phase I-III clinical trials and post-registration studies. However, the particular physiopathology of critically ill patients may significantly alter drug pharmacokinetics. Indeed, changes in interstitial volumes (the third space) and/or in glomerular filtration ratio may influence the achievement of bactericidal concentrations in peripheral compartments, while inflammation can alter the systemic distribution of some drugs. On the contrary, other antibacterial agents may reach high and effective concentrations thanks to the increased tissue accumulation of macrophages and neutrophils. Therefore, the present review explores the tissue distribution of beta-lactams and other antimicrobials acting on the cell wall and cytoplasmic membrane of bacteria in critically ill patients. A systematic search of articles was performed according to PRISMA guidelines, and tissue/plasma penetration ratios were collected. Results showed a highly variable passage of drugs within tissues, while large interindividual variability may represent a hurdle which must be overcome to achieve therapeutic concentrations in some compartments. To solve that issue, off-label dosing regimens could represent an effective solution in particular conditions.

Automated summary

The diffusion of antimicrobial drugs within tissues is crucial for treating infections in critically ill patients. However, the unique physiopathology of these patients can significantly affect the pharmacokinetics of drugs and their distribution in the body. This review explores the tissue distribution of beta-lactams and other antimicrobials in critically ill patients, finding that the passage of drugs within tissues varies greatly and there is a large interindividual variability. Off-label dosing regimens may be an effective solution to overcome these challenges.